Jamaica: CLA Waits on US Scheduling for Banking and a Stock Listing

As of 7 August 2026, the leadership of Jamaica’s Cannabis Licensing Authority says the next stage of the island’s legal ganja industry rests on a decision being taken in Washington. Bank accounts, grants for farmers, and a first cannabis company on the local stock market are all waiting on where the United States finally puts cannabis on its drug schedule.

Authority chair Dr Nadeen Spence, speaking at the Jamaica Observer’s Monday Exchange, said the sector has to “keep our fingers crossed” that cannabis lands at Schedule III, which would “translate into something that reassures the banking sector that ganja is not as risky as it currently is.” Chief Executive Officer Farrah Blake said rescheduling “would answer a lot of questions” about access to the banking system and about eligibility for grants for farmers and businesses in the industry.

The US Department of Justice moved FDA-approved products and state-licensed medical cannabis to Schedule III in April 2026, and the Caribbean read that as an opening on correspondent banking. Months on, the Observer reports it is still not clear where cannabis will sit on the US schedule while lawmakers continue to debate it. Jamaican growers were weighing the same uncertainty in April, when the Ganja Growers Association’s vice president warned that better-capitalised US operators would compete hard against small local farms.

The listing question is at the same stage. The Observer reports no indication of when Jamaica might see its first cannabis company on the local stock market, only that people in the sector expect it to happen. No company has been named and no timeline given.

Walter Melbourne, the Authority’s director of licensing and applications, put the current position against what came before. “In the 1970s, if you were caught with even a small amount it was a mandatory prison sentence,” he said. “Some of our prominent people in society have had trouble.” The Dangerous Drugs (Amendment) Act, 2015 replaced that with a J$500 ticket for two ounces or less, and created the Authority that now regulates the licensed industry.

What This Means

None of this changes what you do on a trip this month. The route is the same one that has been in place since 2015: walk into a licensed herb house, buy a temporary medical authorization for about US$10, keep possession under two ounces, and do not smoke in public. Nothing announced on 7 August touches any of those rules.

Where it does land for travelers is the counter experience over the next year or two. Banking access is what lets licensed operators take card payments reliably, borrow to build, and raise money publicly. If the US question settles, expect the herb houses to look more like retail and less like a permit desk. If it drags, Jamaica’s licensed sector keeps growing on cash and local credit, which is what it has done since the industry reached J$10 billion in 2025.

What to watch: whether US lawmakers settle the classification, and whether the Authority or any licensee names a stock market timeline rather than an ambition.